CLINICAL_TRIALS ClinicalTrials.gov record with results posted

A First-in-Human, Phase 1a/1b, Open Label, Dose-Escalation and Expansion Study to Investigate the Safety, Pharmacokinetics, and Antitumor Activity of the RAF Dimer Inhibitor BGB-3245 in Patients With Advanced or Refractory Tumors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04249843
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-09-01T00:04:58.407677+00:00
Published At: 2026-08-31T00:00:00+00:00
Record Updated At: 2026-08-31
Results Posted At: 2026-08-31
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Solid Tumor", "B-Raf Mutation-Related Tumors"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-08-31"
protocolSection.identificationModule.nctId: "NCT04249843"
protocolSection.identificationModule.officialTitle: "A First-in-Human, Phase 1a/1b, Open Label, Dose-Escalation and Expansion Study to Investigate the Safety, Pharmacokinetics, and Antitumor Activity of the RAF Dimer Inhibitor BGB-3245 in Patients With Advanced or Refractory Tumors"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2026-08-31"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.